Business News • PR NewsWire • EnginZyme raises €21 million in Series B to accelerate the commercialisation of its cell-free biomanufacturing technology

EnginZyme raises €21 million in Series B to accelerate the commercialisation of its cell-free biomanufacturing technology

EnginZyme raises €21 million in Series B to accelerate the commercialisation of its cell-free biomanufacturing technology

STOCKHOLM, Dec. 19, 2022 /PRNewswire/ -- EnginZyme, a green tech company developing biomanufacturing processes for the sustainable manufacturing of everyday products, announced today that it had raised €21 million in a Series B financing round. New investors, including Almi Invest...

View More : https://www.prnewswire.com:443/news-releases/enginzyme-raises-21-million-in-series-b-to-accelerate-the-commercialisation...

Releted News by prnewswire

Autoliv appoints Jonas Jademyr as Executive Vice President, Quality & Program Management

North America last mile delivery market: Growth opportunities led by ArcBest Corp. and AxleHire - Technavio

Initial plan of development completed for Blue Star's world-class Las Animas helium project

Hazardous waste management market: Growth opportunities led by Avalon Holdings Corp, Averda, Bechtel Corp, Chloros Environmental Ltd - Technavio